BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27277572)

  • 1. Exon skipping and aberrant signal peptide cleavage produce novel fibrinogen with an Aα chain lacking the first 42 residues.
    Brennan SO; Laurie AD; McRae S
    Thromb Haemost; 2016 Aug; 116(3):581-5. PubMed ID: 27277572
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel homozygous fibrinogen Aα chain truncation causes severe afibrinogenemia with life threatening complications in a two-year-old boy.
    Stikarová J; Blatný J; Kotlín R; Suttnar J; Zapletal O; Pimková K; Májek P; Hrachovinová I; Dyr JE
    Thromb Res; 2013 Oct; 132(4):490-2. PubMed ID: 24050829
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel gamma230 Asn-->Asp substitution in fibrinogen Middlemore associated hypofibrinogenaemia.
    Brennan SO; Sheen CR; George PM
    Thromb Haemost; 2005 Jun; 93(6):1196-7. PubMed ID: 15968409
    [No Abstract]   [Full Text] [Related]  

  • 4. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
    Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
    Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofibrinogenaemia with novel mutations (γ228Leu→Leu and γ229Gly→Glu) at neighbouring codons; allelic phase and expression level.
    Brennan SO; Laurie AD; Raju N
    Thromb Haemost; 2016 Aug; 116(2):394-6. PubMed ID: 27075301
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia.
    Homer VM; Brennan SO; Ockelford P; George PM
    Thromb Haemost; 2002 Sep; 88(3):427-31. PubMed ID: 12353071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
    Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
    Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three cases of abnormal fibrinogens: sumperk (Bbeta His67Leu), Unicov (Bbeta Gly414Ser), and Brno (gammaArg275His).
    Kotlín R; Reicheltová Z; Sobotková A; Suttnar J; Salaj P; Pospísilová D; Smejkal P; Chrastinová L; Dyr JE
    Thromb Haemost; 2008 Dec; 100(6):1199-200. PubMed ID: 19132250
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
    Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
    Asselta R; Robusto M; Braidotti P; Peyvandi F; Nastasio S; D'Antiga L; Perisic VN; Maggiore G; Caccia S; Duga S
    J Thromb Haemost; 2015 Aug; 13(8):1459-67. PubMed ID: 26039544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
    Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
    Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
    Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
    Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Cordoba I: A gammaArg 275 His substitution associated with defective polymerization.
    Guglielmone HA; Minoldo S; Jarchum GD; Daga DA; Bocco JL
    Thromb Res; 2007; 121(3):429-30. PubMed ID: 17604827
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.
    Brennan SO; Fellowes AP; Faed JM; George PM
    Blood; 2000 Mar; 95(5):1709-13. PubMed ID: 10688828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene.
    Monaldini L; Asselta R; Duga S; Peyvandi F; Ghosh K; Malcovati M; Tenchini ML
    Haematologica; 2006 May; 91(5):628-33. PubMed ID: 16670068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala -->Val substitution (fibrinogen Dorfen).
    Dear A; Brennan SO; Dempfle CE; Kirschstein W; George PM
    Thromb Haemost; 2004 Dec; 92(6):1291-5. PubMed ID: 15583736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Lima. A new dysfibrinogenaemia with a high-molecular-weight alpha-chain and effective polymerization.
    Arocha-Piñango CL; Rodriguez S; Nagy H; Perez Requejo JL
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):561-5. PubMed ID: 2133234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.